US Court vacates Teva exclusivity on generic antipsychotic drug
As a result of this decision, the FDA is no longer enjoined from approving subsequent abbreviated new drug applications. Teva intends to seek a stay of this decision
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.